8-K ·Filed May 7, 2026

GPRE

Green Plains Inc.
MIXED
Impact 7/10
Horizonweeks Processed4mo ago SEC0001309402-26-000058
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The massive EPS beat and raised 45Z credit guidance signal near-term cash flow strength, but the revenue decline from divestitures clouds underlying growth. Watch for organic volume trends and any policy changes to 45Z credits. The stock may react positively to the beat and guidance, but the revenue drag caps upside.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GPRE ▲ +1.09% at T+60d
NEUTRAL call ✓ call won +1.09% · α vs SPY -2.74% · entry $16.46 → $16.64
Entry anchored
May 7, 2026
via day open
T+1d
+10.51%
call +10.51% · α +9.68%
$18.19
settled 5mo ago
T+5d
+2.13%
call +2.13% · α +0.62%
$16.81
settled 5mo ago
T+20d
-3.40%
call -3.40% · α -6.54%
$15.90
settled 4mo ago
T+60d
+1.09%
call +1.09% · α -2.74%
$16.64
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Green Plains reported Q1 2026 EPS of $0.42, far above the -$0.01 consensus, with adjusted EBITDA of $71.5M including $55.2M in 45Z tax credits. Revenue fell 25.9% to $445.8M due to the Obion plant sale and ceased marketing agreement, but underlying ethanol margins improved dramatically. Management raised its 2026 45Z-related EBITDA guidance to $200-225M.

Key Financial Metrics

EPS
$0.42
est $-0.01 · +4300.0%
Revenue
$445.8M
-25.9% YoY
Rating
beat

Key Facts

  • Q1 2026 EPS $0.42 diluted vs consensus -$0.01
  • Revenue $445.8M, down 25.9% YoY primarily from divestiture and marketing agreement termination
  • Adjusted EBITDA $71.5M vs ($24.2M) in prior year
  • 45Z production tax credits contributed $55.2M to adjusted EBITDA
  • Raised 2026 45Z EBITDA guidance to $200-225M from ~$188M
  • SG&A reduced to $19.5M from $42.9M YoY
  • Ethanol crush margin turned positive at $64.6M vs ($14.7M) YoY
  • Early adopted ASU 2025-10, reclassifying 45Z credits to reduce COGS

Financial Impact

EPS beat by $0.43 (4300%) vs consensus; revenue decline of $155.7M (25.9%) but structural; EBITDA swing of +$95.7M

epsrevenueebitdaguidancesg&a

Risk Factors

  • Revenue decline from Obion plant sale and lost marketing volume may persist
  • 45Z tax credit program subject to policy/legislative risk
  • Commodity margin volatility (ethanol, corn, RINs)
  • High debt leverage ($492.2M total debt) with rising interest expense

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Organic Chemicals
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001309402-26-000058
Document: gpreq12026earningsrelease.htm0001309402-26-000058
Document: gpre-20260507.htm0001309402-26-000058
Document: 0001309402-26-000058-index-headers.html0001309402-26-000058
Document: 0001309402-26-000058-index.html0001309402-26-000058
Document: 0001309402-26-000058.txt0001309402-26-000058
8-K Data (Synthetic)0001309402-26-000058
5 reports for GPRE
Performance horizon
Filters
Rows
Reports for GPRE — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
MIXED ★ 5/10
$15.20 $14.96▼ −1.58%▼ −2.18%$15.23 (+0.20%)
Jun 22, 2026
14w ago
S-3ASR
NEUTRAL ★ 4/10
$14.41 $16.83▲ +16.79%▲ +15.63%$15.23 (+5.69%)
May 7, 2026
21w ago
8-K
MIXED ★ 7/10
$16.46 $15.90▼ −3.40%▼ −6.54%$15.23 (−7.47%)
Apr 24, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$16.46 $15.83▼ −3.83%▼ −8.78%$15.23 (−7.47%)
Apr 23, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$15.92 $15.07▼ −5.34%▼ −9.37%$15.23 (−4.33%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (38h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access